Company Overview of King Pharmaceuticals LLC
King Pharmaceuticals LLC develops, manufactures, and markets prescription pharmaceutical products and animal health products worldwide. It offers branded prescription pharmaceuticals including neuroscience products such as Skelaxin, Flector Patch, Avinza, and Embeda; hospital products such as Thrombin-JMI; and legacy products including Levoxyl, Bicillin, Altace, and Cytomel to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons, and hospitals. The company’s animal health business focuses on medicated feed additives and water-soluble therapeutics which are anti-infective products primarily for poultry, cattle, and swine markets. It also manufac...
501 Fifth Street
Bristol, TN 37620
Founded in 1993
Key Executives for King Pharmaceuticals LLC
Executive Vice President of Managed Markets, Government Trade and Public Policy
Chief Legal Officer and Corporate Secretary
Executive Vice President of Technical Operations and Manufacturing
Corporate Compliance Officer
Compensation as of Fiscal Year 2014.
King Pharmaceuticals LLC Key Developments
King Pharmaceuticals LLC to Pay $2.2 Million Civil Penalty
Jun 29 13
King Pharmaceuticals LLC will pay $2.2 million and take measures to comply with the Clean Air Act to resolve alleged violations of the Clean Air Act (CAA) at its pharmaceutical manufacturing facility located in Bristol, Tenn., announced the Department of Justice, the U.S. Environmental Protection Agency (EPA), and the Tennessee Department of Environment and Conservation (TDEC). From the $2.2 million civil penalty, $1.1 million will be paid to the United States and $1.1 million will be paid to TDEC. From TDECs $1.1 million penalty, $650,000 will be applied to a TDEC state project for homeowners. The settlement also requires the facility to demonstrate compliance with CAA National Emission Standards for Pharmaceuticals Production (PharmaMACT regulations) and to apply for a Title V permit.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries